Deerfield Beach, FL -- (SBWIRE) -- 04/17/2017 -- Latest industry research report on Antibody drug conjugates Market. Antibody drug conjugates (ADCs), also known as anti-cancer drugs are promising and effective modalities for cancer therapies. The ADCs are prepared by combining two principles i.e. monoclonal antibody specificity and cell killing efficacy of HPAPI (highly potent active pharmaceutical ingredient).

This combinational approach specifically kills the cancer cells by a toxic payload through binding and internalizing ADC into the cancerous cells. Several years of extensive biological research and developments in the pharmaceutical sector have led to the development of the worlds first two ADCs namely Adcetris and Kadcyla for cancer therapy.

Get Free Sample Report Of Antibody drug conjugates Market @ http://www.marketresearchstore.com/report/world-antibody-drug-conjugate-market-opportunities-and-71697#RequestSample

The ADC market is yet dormant as only two drugs are approved and commercialized till date. Adcetris from Seattle Genetics received the FDA approval in 2011 for the treatment of systemic anaplastic large cell lymphoma and Hodgkins lymphoma. Kadcyla, a product from Genentech, used in the treatment of breast cancer received the FDA approval in 2013.

Furthermore, the antibody drug conjugates market is highly potential market with about 27 drugs that are currently under different phases of clinical trials in both solid tumors indications and hematological malignancies. Thus, ADCs hold great opportunities in the field of pharmaceuticals owing to their novel nature and profound therapy modality in comparison to conventional treatments.

Do Inquiry To Buy Report Of Antibody drug conjugates Market @ http://www.marketresearchstore.com/report/world-antibody-drug-conjugate-market-opportunities-and-71697#InquiryForBuying

Extensive R&D and rising incidences of various cancers are the key factors that drive the growth of this market. However, the high cost associated with research activities, stringent regulatory requirements and several challenges associated with the manufacturing of these drugs are restricting the growth of the Antibody drug conjugates market.

The global antibody drug conjugate market is segmented into approved drugs, drugs in pipeline and geography.

Antibody Drug Conjugate Market By Drug Type

Approved ADC Drugs
Adcetris (brentuximab vedotin)
Kadcyla (ado-trastuzumab emtanisine)
Pipelined ADC Drugs

Antibody Drug Conjugate Market By Geography

North America
Europe
Asia-Pacific
LAMEA

About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: 386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/